HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $318,000 | -50.3% | 6,000 | +4.2% | 0.01% | -61.5% |
| Q1 2021 | $640,000 | -32.6% | 5,760 | -47.0% | 0.01% | -45.8% |
| Q3 2020 | $949,000 | -88.4% | 10,868 | -88.1% | 0.02% | -83.1% |
| Q2 2020 | $8,171,000 | +177.6% | 91,237 | +256.2% | 0.14% | +222.7% |
| Q4 2019 | $2,943,000 | +51.8% | 25,617 | +66.7% | 0.04% | +10.0% |
| Q3 2019 | $1,939,000 | +132.8% | 15,371 | +61.3% | 0.04% | +100.0% |
| Q1 2019 | $833,000 | -47.3% | 9,530 | -31.0% | 0.02% | -31.0% |
| Q3 2018 | $1,582,000 | +649.8% | 13,803 | +192.8% | 0.03% | +866.7% |
| Q3 2017 | $211,000 | -31.0% | 4,714 | -50.3% | 0.00% | -57.1% |
| Q3 2015 | $306,000 | -61.5% | 9,493 | -50.6% | 0.01% | -53.3% |
| Q2 2015 | $795,000 | -26.3% | 19,218 | -25.0% | 0.02% | -72.2% |
| Q4 2013 | $1,079,000 | +365.1% | 25,611 | +356.3% | 0.05% | +315.4% |
| Q2 2013 | $232,000 | – | 5,613 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |